Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multimodal opioid-free anesthesia containing esketamine versus opioid-based anesthesia: a systematic review and meta-analysis.

BMC anesthesiology·2026

Same author

Efficacy, tolerability, and safety of 1.5L-lactulose as bowel preparation for patients with inflammatory bowel disease: a randomized, single-blinded trial.

Internal and emergency medicine·2026

Same author

Ellagic acid alleviates ulcerative colitis in a GPR35-dependent manner associated with SDH restoration.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

Same author

N-Glycosylation and Alzheimer's disease: A 2001-2025 global bibliometric landscape revealing emerging diagnostic trends.

Journal of Alzheimer's disease reports·2026

Same author

Association of the Albumin-Bilirubin score with 7-day incident delirium risk following bloodstream infection in critically ill adults: evidence from a propensity-weighted cohort.

BMC infectious diseases·2026

Same author

Renal Tubule-Specific Deletion of Nephrocystin 3 <i>(Nphp3)</i> Causes Infantile Nephronophthisis-like Phenotypes in Mice.

International journal of molecular sciences·2026

Same journal

Association of blood-activating commercial Chinese polyherbal preparation with clinical outcomes in older patients with ischemic cardiovascular or cerebrovascular diseases: a real-world cohort study.

Frontiers in pharmacology·2026

Same journal

Targeting FAP/CAFs to rewire immune-excluded and resistant tumor niches.

Frontiers in pharmacology·2026

Same journal

Fraxini cortex (Qinpi): reframing a traditional heat-clearing botanical drug as a systemic immune-metabolic regulator.

Frontiers in pharmacology·2026

Same journal

Dose-dependent protective effects of theophylline on testicular endocrine function in a rat model of ischemia-reperfusion injury.

Frontiers in pharmacology·2026

Same journal

Hyper-inflammation and immunosuppression: redefining sepsis therapy using modern approaches.

Frontiers in pharmacology·2026

Same journal

Comparing the effects of propofol and sevoflurane anesthesia on cognitive dysfunction in elderly patients after abdominal surgery: a systematic review and meta-analysis of randomised controlled trials.

Frontiers in pharmacology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 1, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Label-free drug discovery.

¹Biochemical Technologies, Science and Technology Division, Corning Incorporated Corning, NY, USA.

Frontiers in Pharmacology

|April 12, 2014

Summary

This summary is machine-generated.

This study introduces a novel label-free drug discovery strategy. It combines phenotypic profiling with computational methods to better understand drug mechanisms of action.

Keywords:

cell phenotypic screen drug safety/toxicity label-free drug discovery lead selection molecular mechanism of action phenotypic screen polypharmacology target identification

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

Related Experiment Videos

Last Updated: May 1, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

Area of Science:

Drug Discovery and Development
Computational Biology
Cellular Phenomics

Background:

Current drug discovery relies heavily on label-dependent, target-based approaches.
Phenotypic screening is regaining interest due to limitations in target-based methods.
A gap often exists between observed phenotypes and underlying molecular mechanisms.

Purpose of the Study:

To present a novel label-free strategy for early drug discovery.
To bridge the gap between phenotypic screening and molecular mechanism deconvolution.
To offer a holistic and kinetic representation of drug effects.

Main Methods:

Utilizing label-free cell phenotypic profiling.
Integrating computational approaches for data analysis.
Applying the strategy to disease-relevant cell models.

Main Results:

The strategy provides a kinetic and holistic view of drug effects.
It facilitates mechanistic deconvolution of drug actions.
Demonstrates a promising approach for early-stage drug discovery.

Conclusions:

The label-free strategy offers a promising alternative to traditional drug discovery methods.
It enhances the understanding of drug-target interactions and mechanisms of action.
This approach can accelerate the identification of effective therapeutics.